FAIRFIELD, Conn., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that it has sold a Calmare® Scrambler Therapy™ medical device to the Veterans Affairs Medical Center in Jamaica Plain, MA. This Calmare device is on site at the Boston area clinic where it continues to successfully treat veterans suffering from chronic pain.
The Calmare Scrambler Therapy device treats intractable cancer pain, chemotherapy-induced peripheral neuropathy (CIPN), failed back surgery syndrome, sciatic and lumbar pain, post-herpetic neuralgia (PHN), post-surgical pain, brachial plexus pain and low back pain (LBP). The VA healthcare system includes more than 150 medical centers and nearly 800 outpatient clinics.
"This sale, our first to a VA medical center, is indicative of the increased interest in our Calmare Scrambler Therapy device by federal health care clinicians over the past several months," said Aris Despo, CTTC's Executive Vice President. "The use of the Calmare medical device by the VA and military services targets the growing number of veterans and military personnel who suffer from chronic pain. Our therapy is complementary to the Department of Veterans Affairs and Department of Defense initiative for new strategies in pain management which they announced as their 'War On Pain' program. The Calmare Scrambler Therapy device provides excellent pain treatment efficacy through a non-invasive procedure, which successfully treats pain without harmful side effects or the use of powerful and potentially addictive drugs. We believe this sale is the first of many as government physicians search for new and effective treatment methods to benefit their patients."
For more information on the federal government's 'War On Pain' program, see http://waronpain.fedprac.com/home.html.
About Competitive Technologies, Inc
Competitive Technologies is a global leader in developing and commercializing innovative products and technologies. CTTC is multifaceted, providing distribution, patent and technology transfer, sales and licensing services. CTTC's staff is focused on the needs of customers and matching those requirements with commercially viable products or technology solutions.
CTTC is the licensed worldwide distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy™" technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. The Calmare® device is currently being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. For more information on the device, visit www.calmarett.com. Visit CTTC's website: www.competitivetech.net.
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on October 27, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.